Angelini Ventures co-leads Series A financing in Neumirna Therapeutics
8th January 2025 Uncategorised 0
Investment to support RNA therapeutics for epilepsy and neurological disorders

More: Angelini Ventures co-leads Series A financing in Neumirna Therapeutics
Source: News
